The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AZN ASTRAZENECA PLC ORD SHS $0.25



Income Statement  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  21248.64 21614.44 17208.86 15591.87 16765.61
Operating Profit/(Loss)  7341.13 8233.06 5012.61 2251.06 1372.99
Net Interest  305.93 625.44 262.07 250.46 268.56
Profit Before Tax  7010.92 7957.66 4703.78 1981.20 800.54
Profit After Tax  5161.27 6444.89 3857.27 1559.13 793.47
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  5161.27 6444.89 3857.27 1559.13 793.47
Attributable to:
Minority Interests  -17.88 -21.23 -18.46 -9.10 -1.29
Equity Holders of Parent Company  5143.39 6423.65 3838.82 1550.03 792.18
 
Continuing EPS
Earnings per Share - Basic  357.67p 471.66p 304.52p 123.71p 62.96p
Earnings per Share - Diluted  355.75p 469.73p 303.91p 123.71p 62.96p
Earnings per Share - Adjusted  428.56p 471.66p 304.52p 123.71p 62.96p
Continuing and Discontinued EPS
Earnings per Share - Basic  357.67p 471.66p 304.52p 123.71p 62.96p
Earnings per Share - Diluted  355.75p 469.73p 303.91p 123.71p 62.96p
Earnings per Share - Adjusted  428.56p 471.66p 304.52p 123.71p 62.96p
 
Dividend per Share  150.30p 168.60p 181.70p 179.70p 169.90p

Balance Sheet  (£ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  4065.91 2236.66 3391.57 3060.64 3141.74
Intangible Assets  14069.75 13410.98 16207.94 15784.11 20900.63
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 129.34 122.42 170.41 360.43
Other Financial Assets  206.94 220.06 239.31 221.35 298.76
Other Non-Current Assets  1454.30 2871.76 1254.38 2330.50 2217.21
  19796.90 18868.80 21215.63 21567.01 26918.78
Current Assets
Inventories  1074.28 1191.69 1267.92 1157.67 1259.27
Trade & Other Receivables  6789.30 6312.34 5187.33 5077.62 4857.82
Cash at Bank & in Hand  7069.04 4871.63 4737.62 5589.45 4086.20
Current Asset Investments  952.29 2749.50 525.38 506.97 524.27
Other Current Assets  166.06 0.00 0.00 0.00 0.00
  16050.97 15125.15 11718.24 12331.72 10727.55
 
Total Assets  35847.86 33993.95 32933.87 33898.73 37646.33
 
Liabilities
Current Liabilities
Borrowings  -79.84 -1280.48 -554.29 -1084.29 -1571.52
Other Current Liabilities  -10641.89 -8855.28 -7998.77 -8649.49 -9562.73
  -10721.72 -10135.77 -8553.06 -9733.78 -11134.24
 
Net Current Assets  5329.25 4989.39 3165.18 2597.94 -406.69
 
Non-Current Liabilities
Borrowings  -5810.18 -4721.70 -5788.37 -5208.00 -5394.94
Provisions  -2547.10 -2064.86 -1848.05 -2057.61 -1464.86
Other Non-Current Liabilities  -1817.08 -1968.34 -2012.92 -2798.06 -7030.06
  -10174.36 -8754.91 -9649.34 -10063.67 -13889.85
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -20896.09 -18890.67 -18202.40 -19797.45 -25024.09
 
Net Assets  14951.78 15103.28 14731.47 14101.27 12622.23
 
Capital & Reserves
Share Capital  224.82 207.84 191.94 191.03 203.03
Share Premium Account  1706.59 1980.57 2155.64 2415.40 2737.62
Other Reserves  1224.37 1255.39 1205.78 1192.24 1298.46
Retained Earnings  11670.18 11514.06 11045.83 10285.02 8370.92
Shareholders Funds  14825.96 14957.85 14599.20 14083.69 12610.03
 
Minority Interests/Other Equity  125.82 145.42 132.27 17.59 12.21
Total Equity  14951.78 15103.28 14731.47 14101.27 12622.23

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  6.82 6.31 9.55 28.89 72.36
PEG - Adjusted  0.71 0.63 -0.27 -0.49 -1.47
Earnings per Share Growth - Adjusted  9.64% 10.06% -35.44% -59.38% -49.10%
Dividend Cover  2.85 2.80 1.68 0.69 0.37
Revenue Per Share  1477.65p 1588.13p 1364.70p 1245.36p 1328.50p
Pre-Tax Profit per Share  487.55p 584.69p 373.02p 158.24p 63.43p
Operating Margin  32.74% 39.67% 28.83% 14.12% 6.21%
Return on Capital Employed  67.14% 74.77% 61.22% 27.76% 52.18%
 
Continuing & Discontinued Operations
Dividend Yield  5.14% 5.67% 6.25% 5.03% 3.73%
Dividend per Share Growth  6.75% 12.18% 7.77% -1.10% -5.45%
Net Asset Value per Share (exc. Intangibles)  53.67p 119.69p -129.01p -135.26p -656.35p
Net Gearing  -7.95% 7.56% 10.99% 4.99% 22.84%

Data is provided by Morningstar


Company Information
Updated Monthly
Company address 2 Kingdom Street, London, W2 6BD, United Kingdom
Company website http://www.astrazeneca....
Market cap(in millions)* £ 51,992.28
Listing/Admission to trading 01 Jun 1993
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
30-Aug-15
FTSE index FTSE All-Share,FTSE Eurotop 300,FTSE 350 High Yield,FTSE 100,FTSE 350 (ex IT),FTSE techMARK All-Share,FTSE All-Share (ex IT),FTSE 350
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SET0
MiFID Status Regulated Market
Exchange market size 500
SEDOL 0989529
ISIN number GB0009895292



ASTRAZENECA share - fundamentals